Legend Biotech (LEGN) Revenue & Revenue Breakdown
Legend Biotech Revenue Highlights
Latest Revenue (Y)
$285.14M
Latest Revenue (Q)
$93.99M
Main Segment (Y)
Joint Steering Committee Service
Main Geography (Y)
UNITED STATES
Legend Biotech Revenue by Period
Legend Biotech Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $285.14M | 143.70% |
| 2022-12-31 | $117.00M | 30.31% |
| 2021-12-31 | $89.79M | 18.65% |
| 2020-12-31 | $75.68M | 32.15% |
| 2019-12-31 | $57.26M | 16.55% |
| 2018-12-31 | $49.13M | - |
Legend Biotech generated $285.14M in revenue during NA 2023, up 143.70% compared to the previous quarter, and up 580.35% compared to the same period a year ago.
Legend Biotech Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $93.99M | 18.28% |
| 2023-12-31 | $79.46M | -17.24% |
| 2023-09-30 | $96.01M | 30.93% |
| 2023-06-30 | $73.33M | 101.81% |
| 2023-03-31 | $36.34M | 31.49% |
| 2022-12-31 | $27.63M | 0.99% |
| 2022-09-30 | $27.36M | 128.56% |
| 2022-06-30 | $11.97M | -70.68% |
| 2022-03-31 | $40.83M | 4.70% |
| 2021-12-31 | $38.99M | 130.99% |
| 2021-09-30 | $16.88M | -16.56% |
| 2021-06-30 | $20.23M | 47.88% |
| 2021-03-31 | $13.68M | -66.45% |
| 2020-12-31 | $40.78M | 247.18% |
| 2020-09-30 | $11.75M | 1.27% |
| 2020-06-30 | $11.60M | 0.47% |
| 2020-03-31 | $11.55M | -40.64% |
| 2019-12-31 | $19.45M | 10.05% |
| 2019-09-30 | $17.67M | 75.22% |
| 2019-06-30 | $10.09M | 0.34% |
| 2019-03-31 | $10.05M | - |
Legend Biotech generated $93.99M in revenue during Q1 2024, up 18.28% compared to the previous quarter, and up 340.14% compared to the same period a year ago.
Legend Biotech Revenue Breakdown
Legend Biotech Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 21 | Dec 20 |
|---|---|---|
| Joint Steering Committee Service | $54.52M | $46.78M |
| Licensing Of Intellectual Property | $4.91M | $5.63M |
Legend Biotech's latest annual revenue breakdown by segment (product or service), as of Dec 21: Joint Steering Committee Service (91.75%), and Licensing Of Intellectual Property (8.25%).
Legend Biotech Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|
| UNITED STATES | $234.73M | $116.60M | $86.37M | - |
| Europe | $15.07M | - | - | - |
| CHINA | $179.00K | $328.00K | $3.42M | - |
| Other Countries | - | $75.00K | - | - |
| North America | - | - | - | $75.68M |
Legend Biotech's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (93.90%), Europe (6.03%), and CHINA (0.07%).
Legend Biotech Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals | $1.83B | $420.15M |
| AMLX | Amylyx Pharmaceuticals | $380.79M | $88.64M |
| APLS | Apellis Pharmaceuticals | $366.28M | $179.14M |
| LEGN | Legend Biotech | $285.14M | $93.99M |
| ZLAB | Zai Lab | $266.72M | $100.50M |
| ASND | Ascendis Pharma | $266.72M | $95.89M |
| BPMC | Blueprint Medicines | $249.38M | $128.18M |
| TVTX | Travere Therapeutics | $145.24M | $62.90M |
| ACLX | Arcellx | $110.32M | $27.38M |
| STOK | Stoke Therapeutics | $8.78M | $4.22M |
| PLRX | Pliant Therapeutics | $1.58M | - |
| KRTX | Karuna Therapeutics | $654.00K | - |
| PCVX | Vaxcyte | - | - |
| DAWN | Day One Biopharmaceuticals | - | $20.07M |
| MDGL | Madrigal Pharmaceuticals | - | $62.17M |
| TERN | Terns Pharmaceuticals | - | - |
| ETNB | 89bio | - | - |
| AKRO | Akero Therapeutics | - | - |
LEGN Revenue FAQ
What is Legend Biotech’s yearly revenue?
Legend Biotech's yearly revenue for 2023 was $285.14M, representing an increase of 143.70% compared to 2022. The company's yearly revenue for 2022 was $117M, representing an increase of 30.31% compared to 2021. LEGN's yearly revenue for 2021 was $89.79M, representing an increase of 18.65% compared to 2020.
What is Legend Biotech’s quarterly revenue?
Legend Biotech's quarterly revenue for Q1 2024 was $93.99M, a 18.28% increase from the previous quarter (Q4 2023), and a 158.67% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $79.46M, a -17.24% decrease from the previous quarter (Q3 2023), and a 187.57% increase year-over-year (Q4 2022). LEGN's quarterly revenue for Q3 2023 was $96.01M, a 30.93% increase from the previous quarter (Q2 2023), and a 250.91% increase year-over-year (Q3 2022).
What is Legend Biotech’s revenue growth rate?
Legend Biotech's revenue growth rate for the last 3 years (2021-2023) was 217.56%, and for the last 5 years (2019-2023) was 397.94%.
What are Legend Biotech’s revenue streams?
Legend Biotech's revenue streams in c 21 are Joint Steering Committee Service, and Licensing Of Intellectual Property. Joint Steering Committee Service generated $54.52M in revenue, accounting 91.75% of the company's total revenue, up 16.56% year-over-year. Licensing Of Intellectual Property generated $4.9M in revenue, accounting 8.25% of the company's total revenue, down -12.80% year-over-year.
What is Legend Biotech’s main source of revenue?
For the fiscal year ending Dec 21, the largest source of revenue of Legend Biotech was Joint Steering Committee Service. This segment made a revenue of $54.52M, representing 91.75% of the company's total revenue.